These efforts were partially successful in reducing the number of possible TRH conformations that might satisfy the 3-D requirements of the receptor site, but left many questions unanswered. For example, Marshall and Font used the active analog approach to design the conformationally restricted TRH analogs l and 2.2 However, modeling efforts could not differentiate between the potential effectiveness of these analogs or even ...